Trials / Completed
CompletedNCT04005417
Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity
Bioavailable Stannous Fluoride Dentifrice Meta-Analyses: Effects on Dentine Hypersensitivity and Enamel Erosion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,036 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stannous fluoride dentifrice | Stannous fluoride (0.454%) dentifrice |
| DRUG | Positive control dentifrice | Positive control dentifrice containing potassium nitrate or arginine. |
| DRUG | Negative control dentifrice | Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%) |
Timeline
- Start date
- 2018-01-08
- Primary completion
- 2018-11-30
- Completion
- 2018-11-30
- First posted
- 2019-07-02
- Last updated
- 2019-07-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04005417. Inclusion in this directory is not an endorsement.